Brochure | June 13, 2024

Sefia™ Cell Therapy Manufacturing Platform: Helping You Deliver What's Next In CAR T Manufacturing

Source: Cytiva
GettyImages-1339300422 CAR T-Cell Immunotherapy

Cell and gene therapy manufacturers ignite hope for the millions of people waiting for a breakthrough treatment. Success on the journey to commercialization requires a platform tailored specifically for cell therapy manufacturing—one that offers flexibility, seamless integration, increased productivity, and automation of key workflow steps

The Sefia™ Cell Therapy Manufacturing Platform is a modular, digitally integrated solution designed to streamline cell therapy manufacturing processes. This platform combines two functionally closed systems: the Sefia Select™ system for automating cell isolation, harvest, and formulation, and the Sefia™ Expansion System for automating cell activation, transduction, and expansion steps.

Explore this end-to-end cell therapy solution transforming cell therapy manufacturing and helping you deliver what’s next in CAR T manufacturing.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene